FDA — authorised 19 January 2001
- Application: BLA103949
- Marketing authorisation holder: SCHERING
- Local brand name: SYLATRON
- Indication: VIAL
- Status: approved
FDA authorised Sylatron on 19 January 2001
Yes. FDA authorised it on 19 January 2001.
SCHERING holds the US marketing authorisation.